Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2012, Article ID 578616, 8 pages
http://dx.doi.org/10.1100/2012/578616
Research Article

High-Sensitivity Troponin T and Copeptin in Non-ST Acute Coronary Syndromes: Implications for Prognosis and Role of hsTnT and Copeptin in Non-STEACS

1Servicio de Cardiología, Hospital Universitario Virgen de la Arrixaca, 30120 Murcia, Spain
2Servicio de Análisis Clínicos, Hospital Universitario Virgen de la Arrixaca, 30120 Murcia, Spain
3Servicio de Cardiología, Hospital General Universitario de Alicante, 03010 Alicante, Spain

Received 24 October 2011; Accepted 28 November 2011

Academic Editor: Gabriele Di Giammarco

Copyright © 2012 Diana Hernández-Romero et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Ross, “Atherosclerosis—an inflammatory disease,” New England Journal of Medicine, vol. 340, no. 2, pp. 115–126, 1999. View at Publisher · View at Google Scholar · View at Scopus
  2. D. Tousoulis, G. Davies, C. Stefanadis, P. Toutouzas, and J. A. Ambrose, “Inflammatory and thrombotic mechanisms in coronary atherosclerosis,” Heart, vol. 89, no. 9, pp. 993–997, 2003. View at Google Scholar · View at Scopus
  3. E. Falk, “Pathogenesis of Atherosclerosis,” Journal of the American College of Cardiology, vol. 47, no. 8, pp. C7–C12, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. E. M. Antman, M. Cohen, P. J. L. M. Bernink et al., “The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making,” Journal of the American Medical Association, vol. 284, no. 7, pp. 835–842, 2000. View at Google Scholar · View at Scopus
  5. J. A. Castillo Moreno, J. L. Ramos Martín, E. Molina Laborda, S. Egea Beneyto, and J. Ortega Bernal, “Usefulness of clinical profiling and exercise testing in the prognostic assessment of patients admitted with chest pain but without high-risk criteria,” Revista Espanola de Cardiologia, vol. 59, no. 1, pp. 12–19, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Tello-Montoliu, F. Marín, V. Roldán et al., “A multimarker risk stratification approach to non-ST elevation acute coronary syndrome: Implications of troponin T, CRP, NT pro-BNP and fibrin D-dimer levels,” Journal of Internal Medicine, vol. 262, no. 6, pp. 651–658, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Gupta and J. A. de Lemos, “Use and misuse of cardiac troponins in clinical practice,” Progress in Cardiovascular Diseases, vol. 50, no. 2, pp. 151–165, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. K. Thygesen and J. S. Alpert, “Universal definition of myocardial infarction,” Journal of the American College of Cardiology, vol. 50, no. 22, pp. 2173–2195, 2007. View at Publisher · View at Google Scholar
  9. G. Amodio, G. Antonelli, L. Varraso, V. Ruggieri, and F. Di Serio, “Clinical impact of the troponin 99th percentile cut-off and clinical utility of myoglobin measurement in the early management of chest pain patients admitted to the Emergency Cardiology Department,” Coronary Artery Disease, vol. 18, no. 3, pp. 181–186, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. J. P. Bassand, C. W. Hamm, D. Ardissino et al., “Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: the Task Force for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes of the European Society of Cardiology,” European Heart Journal, vol. 28, no. 13, pp. 1598–1660, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. K. Thygesen, J. Mair, H. Katus et al., “Recommendations for the use of cardiac troponin measurement in acute cardiac care,” European Heart Journal, vol. 31, no. 18, pp. 2197–2204, 2010. View at Publisher · View at Google Scholar
  12. S. James, P. Armstrong, R. Califf et al., “Troponin T levels and risk of 30-day outcomes in patients with the acute coronary syndrome: prospective verification in the GUSTO-IV trial,” American Journal of Medicine, vol. 115, no. 3, pp. 178–184, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. T. Omland, J. A. De Lemos, M. S. Sabatine et al., “A sensitive cardiac troponin T assay in stable coronary artery disease,” New England Journal of Medicine, vol. 361, no. 26, pp. 2538–2547, 2009. View at Publisher · View at Google Scholar
  14. T. Reichlin, W. Hochholzer, S. Bassetti et al., “Early diagnosis of myocardial infarction with sensitive cardiac troponin assays,” New England Journal of Medicine, vol. 361, no. 9, pp. 858–867, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Agewall, E. Giannitsis, T. Jernberg, and H. Katus, “Troponin elevation in coronary vs. non-coronary disease,” European Heart Journal, vol. 32, no. 4, pp. 404–411, 2011. View at Publisher · View at Google Scholar
  16. T. Keller, S. Tzikas, T. Zeller et al., “Copeptin improves early diagnosis of acute myocardial infaction,” Journal of the American College of Cardiology, vol. 55, no. 19, pp. 2096–2106, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. G. L. Robertson, “Antidiuretic hormone: normal and disordered function,” Endocrinology and Metabolism Clinics of North America, vol. 30, no. 3, pp. 671–694, 2001. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Struck, N. G. Morgenthaler, and A. Bergmann, “Copeptin, a stable peptide derived from the vasopressin precursor, is elevated in serum of sepsis patients,” Peptides, vol. 26, no. 12, pp. 2500–2504, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Q. Khan, O. S. Dhillon, R. J. O'Brien et al., “C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction: Leicester acute myocardial infarction peptide (LAMP) study,” Circulation, vol. 115, no. 16, pp. 2103–2110, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. T. Reichlin, W. Hochholzer, C. Stelzig et al., “Incremental value of copeptin for rapid rule out of acute myocardial infarction,” Journal of the American College of Cardiology, vol. 54, no. 1, pp. 60–68, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. F. S. Apple, A. H. B. Wu, and A. S. Jaffe, “European Society of Cardiology and American College of Cardiology guidelines for redefinition of myocardial infarction: How to use existing assays clinically and for clinical trials,” American Heart Journal, vol. 144, no. 6, pp. 981–986, 2002. View at Publisher · View at Google Scholar · View at Scopus
  22. E. Braunwald, E. M. Antman, J. W. Beasley et al., “ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction—summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina),” Journal of the American College of Cardiology, vol. 40, no. 7, pp. 1366–1374, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. G. Y. H. Lip and A. D. Blann, “Thrombogenesis, atherogenesis and angiogenesis in vascular disease: a new 'vascular triad',” Annals of Medicine, vol. 36, no. 2, pp. 119–125, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. J. L. Januzzi Jr., F. Bamberg, H. Lee et al., “High-sensitivity troponin T concentrations in acute chest pain patients evaluated with cardiac computed tomography,” Circulation, vol. 121, no. 10, pp. 1227–1234, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Tello-Montoliu, F. Marín, V. Roldán, and G. Y. H. Lip, “The additive value of biomarkers to clinical risk scores in acute coronary syndrome. Are biomarkers really ready for real world usage?” Heart, vol. 96, no. 3, pp. 227–228, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. D. A. Morrow, E. M. Antman, M. Tanasijevic et al., “Cardiac troponin I for stratification of early outcomes and the efficacy of enoxaparin in unstable angina: a TIMI-11B substudy,” Journal of the American College of Cardiology, vol. 36, no. 6, pp. 1812–1817, 2000. View at Publisher · View at Google Scholar · View at Scopus
  27. W. Hochholzer, H. J. Buettner, D. Trenk et al., “New definition of myocardial infarction: impact on long-term mortality,” American Journal of Medicine, vol. 121, no. 5, pp. 399–405, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. C. J. McCann, B. M. Glover, I. B. A. Menown et al., “Novel biomarkers in early diagnosis of acute myocardial infarction compared with cardiac troponin T,” European Heart Journal, vol. 29, no. 23, pp. 2843–2850, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. G. Lippi and G. Cervellin, “Letter by lippi and cervellin regarding article, high-sensitivity troponin T concentrations in acute chest pain patients evaluated with cardiac computed tomography,” Circulation, vol. 123, no. 1, article e3, 2011. View at Publisher · View at Google Scholar
  30. J. L. Januzzi Jr., Q. A. Truong, A. A. Mohammed et al., “Reply to letter regarding article, high-sensitivity troponin t concentrations in acute chest pain patients evaluated with cardiac computed tomographyg,” Circulation, vol. 123, no. 1, article e4, 2011. View at Publisher · View at Google Scholar
  31. M. Bonaca, B. Scirica, M. Sabatine et al., “Prospective evaluation of the prognostic implications of improved assay performance with a sensitive assay for cardiac troponin I,” Journal of the American College of Cardiology, vol. 55, no. 19, pp. 2118–2124, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. O. Danne, M. Möckel, C. Lueders et al., “Prognostic implications of elevated whole blood choline levels in acute coronary syndromes,” American Journal of Cardiology, vol. 91, no. 9, pp. 1060–1067, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. N. Gaibazzi, C. Reverberi, and L. Badano, “Usefulness of contrast stress-echocardiography or exercise- electrocardiography to predict long-term acute coronary syndromes in patients presenting with chest pain without electrocardiographic abnormalities or 12-hour troponin elevation,” American Journal of Cardiology, vol. 107, no. 2, pp. 161–167, 2011. View at Publisher · View at Google Scholar